Open Access 01-12-2022 | Migraine | Correction
Correction: Efficacy and safety of fremanezumab in clinical trial participants aged ≥60 years with episodic or chronic migraine: pooled results from 3 randomized, double-blind, placebo-controlled phase 3 studies
Published in: The Journal of Headache and Pain | Issue 1/2022
Login to get access